Skip to main content

Table 1 Patient demographic and clinical characteristics

From: The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression

Characteristic Pre-HIV infection (HIV) Post-HIV infection (HIV+)
Sociodemographic variables
N 54
Sex Male (54/54)
Age, years [median (IQR)]a 32.5 (28, 41)
 < 20 0
 20–30 19
 30–40 20
 40–50 10
 > 50 5
 Unknown 4
Marital status [n/total (%)]
 Unmarried 45 (83%)
 Married 6 (11%)
 Divorced 3 (6%)
MSM 54/54
Chinese 54/54
Ethnicity Han (45/54)
Man (7/54)
Other (2/54)
Clinical
HBV Ag N/A 4/54
HCV Ab N/A 1/54
TPPA N/A 26/54
Fiebig staging
 I–II 14
 III–IV 16
 V–VI 24
Estimated infection day (days) [median (IQR)]a − 91 (− 141, − 56) 31 (25, 49)
Methods for estimating infection day (N)
 i. Fiebig stage N/A 6
 ii. Remembered time of high-risk exposure N/A 24
 iii. Laboratory HIV antibody detection N/A 24
 Follow-up (days) [median (IQR)]a N/A 1719 (1142, 2625)
CD4+T-cell count (cells/μL) [median (IQR)]a
Chemokine detection sampling point N/A 424 (328, 531)
Set-point N/A 488 (390, 634)
One-year-infection pointb N/A 412 (328, 555)
Viral load (copies/mL) [median (IQR)]a
Chemokines detection sampling point N/A 78,500 (11,370, 753,000)
Set-point N/A 24,900 (8450, 83,050)
One-year-infection pointb N/A 22,887 (8482.5, 36,600)
Viral subtype [N/total] CRF-01AE (53/54)
CRF-01AE/BC (1/54)
  1. N/A not applicable, MSM men who have sex with men
  2. aData presented as median (IQR, interquartile range)
  3. bAntiretroviral therapy-naïve patient at 1-year-infection point